학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 660건 | 목록 1~20
Academic Journal
EBioMedicine, Vol 118, Iss , Pp 105873- (2025)
Academic Journal
Schmid J; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Alberti C; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Power L; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Nuñez NG; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Centro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET, X5000HUA Córdoba, Argentina.; De Feo D; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Tyystjärvi S; Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine and Health, 81675 Munich, Germany.; Kulsvehagen L; Departments of Neurology, Biomedicine, and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel and University of Basel, CH-4031 Basel, Switzerland.; Kreiner V; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Ayroza Bleher AB; Departments of Neurology, Biomedicine, and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel and University of Basel, CH-4031 Basel, Switzerland.; Lipps P; Departments of Neurology, Biomedicine, and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel and University of Basel, CH-4031 Basel, Switzerland.; Swinnen S; Laboratory for Neuroimmunology, Department of Neurosciences, and Department of Neurology, Leuven Brain Institute, KU Leuven, University Hospitals Leuven, 3000 Leuven, Belgium.; Ingelfinger F; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Ulutekin C; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Chaubet C; Institute for Inflammatory and Infectious Diseases, INSERM UMR1291-CNRS UMR505, 31024 Toulouse, France.; Unger S; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Kreutmair S; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zurich, CH-8091 Zurich, Switzerland.; LOOP Zurich, CH-8044 Zurich, Switzerland.; Marignier R; Centre de Recherche en Neurosciences de Lyon, INSERM U1028-CNRS UMR5292, 69675 Bron, France.; Korn T; Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine and Health, 81675 Munich, Germany.; Munich Cluster for Systems Neurology, 81377 Munich, Germany.; Pröbstel AK; Departments of Neurology, Biomedicine, and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel and University of Basel, CH-4031 Basel, Switzerland.; Center of Neurology, Department of Neuroimmunology, University Hospital and University Bonn, 53127 Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.; Liblau R; Institute for Inflammatory and Infectious Diseases, INSERM UMR1291-CNRS UMR505, 31024 Toulouse, France.; Department of Immunology, Toulouse University Hospital, 31300 Toulouse, France.; Becher B; Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.; LOOP Zurich, CH-8044 Zurich, Switzerland.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Chaves B; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Structural and Functional Biology of Biopharmaceuticals, Fiocruz-Ceará, Oswaldo Cruz Foundation (Fiocruz), Eusébio, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Santos E Silva JC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.; Nakaya H; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Socquet-Juglard N; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Bucciarelli F; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Department of Neurosciences, Toulouse University Hospitals, Toulouse, France.; Prunier G; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Almeida MV; Structural and Functional Biology of Biopharmaceuticals, Fiocruz-Ceará, Oswaldo Cruz Foundation (Fiocruz), Eusébio, Brazil.; Lacouture C; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Kari S; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Astier AL; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Medeiros MA; Laboratory of Recombinant Technology, Bio-Manguinhos, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Silva JHM; Structural and Functional Biology of Biopharmaceuticals, Fiocruz-Ceará, Oswaldo Cruz Foundation (Fiocruz), Eusébio, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France.; Department of Immunology, Toulouse University Hospitals, Toulouse, France.; Cotta-de-Almeida V; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. vinicius.almeida@fiocruz.br.; Laboratory on Thymus Research (LPT), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. vinicius.almeida@fiocruz.br.; Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil. vinicius.almeida@fiocruz.br.; Dupré L; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM U1291, CNRS UMR5051, Toulouse University, Toulouse, France. loic.dupre@inserm.fr.; Department of Dermatology, Medical University of Vienna, Vienna, Austria. loic.dupre@inserm.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Martin-Blondel G; Department of Infectious and Tropical Diseases, Toulouse University Hospital, 31059 Toulouse, France.; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, 31024 Toulouse, France.; NEO-I3D Research Group, Toulouse University Hospital, 31059 Toulouse, France.; Burgat P; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Leducq V; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.; Porrot F; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Cottignies-Calamarte A; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Antiviral Activities of Antibodies Group, Institut Pasteur, Université Paris Cité, Paris, France.; De Cruz A; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Antiviral Activities of Antibodies Group, Institut Pasteur, Université Paris Cité, Paris, France.; Dorival C; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Romieu-Mourez R; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, 31024 Toulouse, France.; Chaubet C; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, 31024 Toulouse, France.; Cazaentre V; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, 31024 Toulouse, France.; Boumaza X; Department of Infectious and Tropical Diseases, Toulouse University Hospital, 31059 Toulouse, France.; Richier Q; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Hôpital Saint-Antoine, Service de Maladies Infectieuses et Tropicales, Paris, France.; Gaborit B; Department of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique 1413, INSERM, Nantes 1064, France.; Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.; Coustilleres F; Department of Infectious and Tropical Diseases, Tours University Hospital, Tours 37044 cedex9, France.; Dubée V; Service des Maladies Infectieuses et Tropicales, CHU d'Angers, Angers, France.; Ader F; Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, 69004 Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University Lyon, Lyon 69007, France.; Yordanov Y; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; HCL, Hôpital Edouard Herriot, Service d'Accueil Des Urgences, Samu 69, Lyon, France.; Schwartz O; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Vaccine Research Institute, Créteil, France.; Marcelin AG; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.; Lusivika-Nzinga C; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Carrat F; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Département de Santé Publique, Hôpital Saint-Antoine, AP-HP Paris, Paris, France.; Soulié C; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et Santé Publique (IPLESP), Paris, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, 31024 Toulouse, France.; Department of Immunology, Toulouse University Hospital, Toulouse, France.; Bruel T; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Antiviral Activities of Antibodies Group, Institut Pasteur, Université Paris Cité, Paris, France.; Vaccine Research Institute, Créteil, France.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Academic Journal
Debonlier A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Kari S; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Bucciarelli F; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Angles T; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Perez-Pestel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Fébrissy C; Université de Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1297, France.; Laffont S; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.; Lenfant F; Université de Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1297, France.; Dunn SE; Sunnybrook Research Institute, University of Toronto, Ontario, Canada; and.; Guillermet-Guibert J; Centre de recherche en cancérologie (CRCT)-Oncopole, Inserm UMR1037, CNRS UMR5071, Université de Toulouse, France.; Astier AL; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051, Université de Toulouse, France.
Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE
Academic Journal
de Sèze J; Service de Neurologie et Centre d'Investigation Clinique, CHU de Strasbourg, INSERM 1434, Strasbourg, France. Jerome.DESEZE@chru-strasbourg.fr.; Labauge P; Service de Neurologie, CHU de Montpellier, 34295, Montpellier Cedex 5, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, Institut National de la Santé et de la Recherche Médicale (INSERM), UPS, Toulouse, France.; Department of Immunology, Toulouse University Hospital, Toulouse, France.; Martinez M; CH de Dax, Dax, France.; Moreau T; Service de Neurologie, CHU de Dijon, Dijon, France.; Suchet L; Department of Neurology, Hôpital Européen de Marseille, Marseille, France.; Vermersch P; Univ. Lille, INSERM U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.; Vukusic S; Hospices Civils de Lyon, Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, 69677, Bron, France.; Observatoire Français de La Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, 69003, Lyon, France.; Université de Lyon, Université Claude Bernard Lyon 1, 69000, Lyon, France.; Eugène Devic EDMUS Foundation Against Multiple Sclerosis (A Government-Approved Foundation), 69677, Bron, France.; Mathey G; Nancy University Hospital, Department of Neurology, Nancy, France.; Université de Lorraine, APEMAC, 54000, Nancy, France.; Michel L; Neurology Department, Clinical Neuroscience Centre, CIC_P1414 INSERM, Rennes, University Hospital, Rennes University, Rennes, France.; Ciron J; CHU de Toulouse, CRC-SEP, Department of Neurology, 31059, Toulouse Cedex 9, France.; Université Toulouse III, Infinity, INSERM UMR1291-CNRS UMR5051, 31024, Toulouse Cedex 3, France.; Ruet A; Department of Neurology, University Hospital of Bordeaux, 33076, Bordeaux, France.; Neurocentre Magendie, Bordeaux University, INSERM U1215, 33000, Bordeaux, France.; Maillart E; Département de Neurologie, Hôpital Pitié-Salpêtrière, APHP, Paris, France.; Centre de Ressources et de Compétences SEP, Paris, France.; Zephir H; CHU Lille, CRC-SEP Lille, Univ Lille, U1172, 59000, Lille, France.; Papeix C; Fondation Rotschild, Department of Neurology, 75000, Paris, France.; Defer G; CHU de Caen, MS Expert Centre, Department of Neurology, Normandy University, 14033, Caen, France.; Cohen M; Neurology, UR2CA_URRIS, Centre Hospitalier Universitaire Pasteur 2, Université Nice Côte d'Azur, Nice, France.; Laplaud DA; Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, CIC INSERM 1413, Service de Neurologie, 44000, Nantes, France.; Berger E; CHU de Besançon, Service de Neurologie, 25030, Besançon, France.; Clavelou P; CHU Clermont-Ferrand, Department of Neurology, 63000, Clermont-Ferrand, France.; Université Clermont Auvergne, INSERM, Neuro-Dol, 63000, Clermont-Ferrand, France.; Thouvenot E; Department of Neurology, Nimes University Hospital, 30029, Nimes Cedex 9, France.; IGF, University of Montpellier, CNRS, INSERM, 34094, Montpellier Cedex 5, France.; Heinzlef O; Hôpital de Poissy, Department of Neurology, 78300, Poissy, France.; Pelletier J; Aix Marseille Univ, APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, 13005, Marseille, France.; Giannesini C; Sorbonne Université; Department of Neurology, AP-HP, Saint-Antoine Hospital, 75000, Paris, France.; Casez O; CHU Grenoble Alpes, Department of Neurology, Neurology MS Clinic Grenoble, Grenoble Alpes University Hospital, Grenoble, 38700, La Tronche, France.; T-RAIG, TIMC-IMAG, Grenoble Alpes University, Grenoble, France.; Bourre B; CHU de Rouen, Department of Neurology, 76000, Rouen, France.; Wahab A; APHP, Hôpital Henri Mondor, Department of Neurology, 94000, Créteil, France.; Magy L; CHU de Limoges, Hôpital Dupuytren, Department of Neurology, 87000, Limoges, France.; Camdessanché JP; CHU de Saint-Étienne, Hôpital Nord, Department of Neurology, 42000, Saint-Étienne, France.; Doghri I; CHU de Tours, Hôpital Bretonneau, CRC-SEP and Department of Neurology, 37000, Tours, France.; Labeyrie C; CHU Bicêtre, Department of Neurology, 94275, Le Kremlin Bicêtre, France.; Hankiewicz K; Department of Neurology, Hôpital Pierre Delafontaine, Centre Hospitalier de Saint-Denis, 93200, Saint-Denis, France.; Neau JP; CHU La Milétrie, Hôpital Jean Bernard, Department of Neurology, 86000, Poitiers, France.; Pottier C; CH de Pontoise, Hôpital René Dubos, Department of Neurology, 95300, Pontoise, France.; Dobay P; Biogen International GmbH, Baar, Switzerland.; Li H; Previously: Biogen, Cambridge, MA, USA.; Levin S; Biogen, Cambridge, MA, USA.; Gros M; Biogen France, 92400, Courbevoie, France.; Ruiz M; Biogen France, 92400, Courbevoie, France.; Rollot F; Université de Lyon, Université Claude Bernard Lyon 1, 69000, Lyon, France.; Hospices Civils de Lyon, Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, 69677, Bron, France.; Observatoire Français de La Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, 69003, Lyon, France.; Eugène Devic EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, 69677, Bron, France.
Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Academic Journal
Giordano A; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Department of Neurology and MS Center, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.; Pignolet B; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, Toulouse, France.; Neurosciences Department, Toulouse University Hospital, Toulouse, France.; Mascia E; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Clarelli F; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Sorosina M; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Misra K; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Bucciarelli F; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, Toulouse, France.; Ferrè L; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Department of Neurology and MS Center, IRCCS Ospedale San Raffaele, Milan, Italy.; Moiola L; Department of Neurology and MS Center, IRCCS Ospedale San Raffaele, Milan, Italy.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, Toulouse, France.; Department of Immunology, Toulouse University Hospitals, Toulouse, France.; Filippi M; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Department of Neurology and MS Center, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.; Esposito F; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Department of Neurology and MS Center, IRCCS Ospedale San Raffaele, Milan, Italy.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Academic Journal
Kari S; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Bucciarelli F; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Angles T; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Oster AC; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Cauboue P; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Laviolette K; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Mougenot M; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Morandi E; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Bernard I; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Pignolet B; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; CRC-SEP, Neurosciences Department, Toulouse University Hospital, Toulouse, France.; Bost C; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Immunology Department Laboratory, Institut Fédératif de Biologie, Toulouse University Hospital Center, Toulouse, France.; Thomas J; CNRS UMR-5284, INSERM U-1314, MeLiS, Institut NeuroMyoGène, Universite de Lyon-Université Claude Bernard Lyon 1, Lyon, France.; Nogueira L; Laboratory of Cell Biology and Cytology, Toulouse University Hospital, Toulouse, France.; Saoudi A; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.; Astier AL; Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Cedex 3, France.
Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Academic Journal
Tran TT; Department of Biobank, Hi-Tech Center and Vinmec-VinUni Institute of Immunology, Vinmec Healthcare system, Hanoi, Vietnam.; Nguyen TN; Department of Biobank, Hi-Tech Center and Vinmec-VinUni Institute of Immunology, Vinmec Healthcare system, Hanoi, Vietnam.; Dauvilliers Y; Department of Neurology, Sleep-Wake Disorder Center, CHU Montpellier, Montpellier, France.; Liblau R; Department of Inflammatory Diseases of the Central Nervous System: Mechanisms and Therapies, Toulouse Institute for Infection and Inflammatory Diseases, University of Toulouse, Toulouse, France.; Nguyen XH; Department of Biobank, Hi-Tech Center and Vinmec-VinUni Institute of Immunology, Vinmec Healthcare system, Hanoi, Vietnam.; College of Health Sciences, VinUnivesity, Hanoi, Vietnam.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Faure F; Synaptopathies and Autoantibodies (SynatAc) Team, Institut NeuroMyoGène (INMG)-MeLis, INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, 69373, Lyon, France.; Yshii L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024, Toulouse, France.; Department of Immunology, Toulouse University Hospital, 31300, Toulouse, France.; Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000, Louvain, Belgium.; Department of Neurosciences, KU Leuven, 3000, Louvain, Belgium.; Renno T; Cancer Research Centre of Lyon, Université de Lyon, INSERM 1052, CNRS 5286, 69008, Lyon, France.; Coste I; Cancer Research Centre of Lyon, Université de Lyon, INSERM 1052, CNRS 5286, 69008, Lyon, France.; Joubert B; Synaptopathies and Autoantibodies (SynatAc) Team, Institut NeuroMyoGène (INMG)-MeLis, INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, 69373, Lyon, France.; French Reference Centre On Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France.; Desestret V; Synaptopathies and Autoantibodies (SynatAc) Team, Institut NeuroMyoGène (INMG)-MeLis, INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, 69373, Lyon, France.; French Reference Centre On Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024, Toulouse, France.; Department of Immunology, Toulouse University Hospital, 31300, Toulouse, France.; Honnorat J; Synaptopathies and Autoantibodies (SynatAc) Team, Institut NeuroMyoGène (INMG)-MeLis, INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, 69373, Lyon, France. jerome.honnorat@chu-lyon.fr.; French Reference Centre On Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France. jerome.honnorat@chu-lyon.fr.
Publisher: Springer Country of Publication: United States NLM ID: 101089443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4230 (Electronic) Linking ISSN: 14734222 NLM ISO Abbreviation: Cerebellum Subsets: MEDLINE
Academic Journal
Khajavi L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique (CNRS), L'Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paul-Sabatier de Toulouse (UPS), Toulouse, France.; Applied Mathematics and Informatics Unit of Toulouse (MIAT), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Toulouse, France.; Nguyen XH; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique (CNRS), L'Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paul-Sabatier de Toulouse (UPS), Toulouse, France.; Vinmec Institute of Applied Science and Regenerative Medicine, Vinmec Healthcare System and College of Health Sciences, VinUniveristy, Hanoi, Vietnam.; Queriault C; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique (CNRS), L'Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paul-Sabatier de Toulouse (UPS), Toulouse, France.; Chabod M; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique (CNRS), L'Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paul-Sabatier de Toulouse (UPS), Toulouse, France.; Barateau L; National Reference Center for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalier Universitaire (CHU) de Montpellier, Montpellier, France.; Institute for Neurosciences of Montpellier (INM), University Montpellier, Montpellier, France.; Dauvilliers Y; National Reference Center for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalier Universitaire (CHU) de Montpellier, Montpellier, France.; Institute for Neurosciences of Montpellier (INM), University Montpellier, Montpellier, France.; Zytnicki M; Applied Mathematics and Informatics Unit of Toulouse (MIAT), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Toulouse, France.; Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique (CNRS), L'Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paul-Sabatier de Toulouse (UPS), Toulouse, France.; Department of Immunology, Toulouse University Hospital, Toulouse, France.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Liblau, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어